aspira womens health inc shares plummeted 23 to 68 cents in afterhours trading monday after it announced a public offering of its shares and warrants the austin texasbased bioanalytical company focused on gynecologic disease said the offering is subject to market and other conditions and the size of the offering wasnt disclosed william blair  co llc is acting as the sole bookrunning manager for the proposed offering aspira plans to use the proceeds for working capital and other general corporate purposes including product portfolio expansion and commercialization aspira may also use a portion of the net proceeds from the offering to invest in complimentary businesses strategic partnerships technologies or other intellectual property